Wood A J, Villeneuve J P, Branch R A, Rogers L W, Shand D G
Gastroenterology. 1979 Jun;76(6):1358-62.
The elimination of propranolol by perfused livers of rats made cirrhotic by chronic carbon tetrachloride inhalation during phenobarbital treatment has been compared with control animals receiving only phenobarbital. Cirrhosis reduced propranolol clearance at a constant flow of 20 ml/min from 1.43 +/- 0.08 to 1.12 +/- 0.08 ml/min/g liver (P less than 0.025). In addition, an increase in intrahepatic shunting of 15-micron microspheres from 0.41 +/- 0.01 to 9.4 +/- 4.1% was found in cirrhotic livers (P less than 0.05). Finally, in cirrhotic livers, reducing blood flow did not produce the normal rise in hepatic extraction ratio, which actually fell from 0.873 +/- 0.021 at 20 ml/min to 0.836 +/- 0.025 at 15 ml/min and 0.823 +/- 0.026 at 10 ml/min. At each flow the observed extraction was significantly lower than that predicted to result from a reduced enzyme activity alone, consistent with the development of functionally significant intrahepatic shunts. An operational model is proposed that explains impaired drug metabolism in cirrhosis on the basis of the development of intrahepatic shunts which perfuse nonfunctioning tissue, while the remaining blood flow is exposed to a reduced mass of hepatocytes with an apparently normal amount of drug metabolizing enzyme (the intact hepatocyte theory).
在苯巴比妥治疗期间,通过慢性吸入四氯化碳使大鼠肝脏形成肝硬化,将这种肝硬化大鼠的灌注肝脏对普萘洛尔的清除情况与仅接受苯巴比妥治疗的对照动物进行了比较。在20毫升/分钟的恒定流速下,肝硬化使普萘洛尔的清除率从1.43±0.08降至1.12±0.08毫升/分钟/克肝脏(P<0.025)。此外,在肝硬化肝脏中发现15微米微球的肝内分流增加,从0.41±0.01%增至9.4±4.1%(P<0.05)。最后,在肝硬化肝脏中,降低血流并未使肝提取率出现正常升高,实际上肝提取率从20毫升/分钟时的0.873±0.021降至15毫升/分钟时的0.836±0.025以及10毫升/分钟时的0.823±0.026。在每个流速下,观察到的提取率均显著低于仅因酶活性降低所预测的结果,这与功能性显著的肝内分流的形成一致。提出了一个操作模型,该模型基于灌注无功能组织的肝内分流的形成来解释肝硬化中药物代谢受损的情况,而其余血流则暴露于肝细胞数量减少但药物代谢酶量明显正常的环境中(完整肝细胞理论)。